Is Eloxx Pharmaceuticals, Inc. (ELOX) a Buy, Sell, or Hold?
NASDAQ : ELOX
Eloxx Pharmaceuticals, Inc.
$12.33 USD
$0.33 (2.75%)
- Volume
- 41.54K
- Average Volume
- 57.17K
- Market Capitalization
- $93.37M
- P/E Ratio
- -2.11
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $17.50
- Year Low
- $8.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.48
Company Overview
NASDAQ
Sumit Aggarwal
Biotechnology
Healthcare
ELOX
10
US
USD
Liquidity Metrics
0.00
0.48
0.48
0.40
0.00
Sales & Valuation
-$
0.00
-7.12
-21.98
-0.97
Profitability
-$5.39
-$6M
0.00%
0.00%
72.03%
-64.25%
P/E Metrics
-2.11
-0.02
-0.02
Analyst Price Target & Rating
$43.00
$43.00
$43.00
2/5
11 Analysts
-71.33%
Company Executives
| Name | Title |
|---|---|
| Daniel E. Geffken | Interim Chief Financial Officer |
| Sumit Aggarwal | President, Chief Executive Officer & Director |
| Roger Clark | VP & Head of Discovery Sciences |
| Teji Singh | VP & Head of Clinical Development |
| John Woolford | VP & Head of Corporate Development |
| Ali Hariri | Chief Medical Officer |
| Barbara Ryan | Investor Relations Officer |
Poll Results
No votes yet today — be the first to share your view!
About Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Stock
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Its primary objective is to address rare and ultra-rare genetic diseases that arise from premature stop codons. The company's most advanced investigational compound, ELX-02, is currently progressing through Phase 2 clinical trials. This candidate is being evaluated for its potential to treat patients with cystic fibrosis and nephropathic cystinosis who possess diagnosed nonsense mutations. In addition to its lead program, Eloxx is actively pursuing several preclinical projects aimed at conditions like Alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis. The company als ... o maintains various earlier-stage discovery initiatives focused on oncology. Eloxx Pharmaceuticals was established in 2013 and is headquartered in Watertown, Massachusetts.
2026-06-08 21:23:00
ARLINGTON, Mass., June 8, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) ("Eloxx" and the "Company"), a clinical-stage biopharmaceutical company developing novel, small molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations to enable the production of full-length proteins, today announced the pricing of a public offering of 2,975,000 shares of common stock at a public offering price of $11.00 per share and, in lieu of shares of common stock, pre-funded warrants to purchase up to 3,025,000 shares of common stock at a public offering price of $10.99 per pre-funded warrant, which equals the public offering price per share of the common stock less the $0.01 per share exercise price of each pre-funded warrant.
Frequently Asked Questions
-
What is the current Eloxx Pharmaceuticals, Inc. (ELOX) stock price?
-
Eloxx Pharmaceuticals, Inc.(NASDAQ:ELOX) stock price is $12.33 in the last trading session. During the trading session, ELOX stock reached the peak price of $17.5 while $8.2 was the lowest point it dropped to. The percentage change in ELOX stock occurred in the recent session was 2.75% while the dollar amount for the price change in ELOX stock was $0.33.
-
ELOX's industry and sector of operation?
-
The NASDAQ listed ELOX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ELOX?
-
Daniel E. Geffken | Interim Chief Financial Officer
Sumit Aggarwal | President, Chief Executive Officer & Director
Roger Clark | VP & Head of Discovery Sciences
Teji Singh | VP & Head of Clinical Development
John Woolford | VP & Head of Corporate Development -
How many employees does ELOX have?
-
Number of ELOX employees currently stands at 10. ELOX operates from P.O. Box 274, Watertown, MA 02472, US.
-
Link for ELOX official website?
-
Official Website of ELOX is: https://www.eloxxpharma.com
-
How do I contact ELOX?
-
ELOX could be contacted at phone #781 577 5300 and can also be accessed through its website. ELOX operates from P.O. Box 274, Watertown, MA 02472, US.
-
How many shares of ELOX are traded daily?
-
The average number of ELOX shares traded daily for last 3 months was 57.17K.
-
What is the market cap of ELOX currently?
-
The market value of ELOX currently stands at $93.37M with its latest stock price at $12.33